Cargando…

Efficacy of Olopatadine versus Epinastine for Treating Allergic Conjunctivitis Caused by Japanese Cedar Pollen: A Double-Blind Randomized Controlled Trial

INTRODUCTION: The objective of this study was to compare the efficacy and safety of olopatadine versus epinastine in healthy Japanese adults with a history of allergic conjunctivitis to Japanese cedar pollen. METHODS: This Phase IV double-blind randomized controlled clinical trial comprised three cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukushima, Atsuki, Ebihara, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209092/ https://www.ncbi.nlm.nih.gov/pubmed/25269854 http://dx.doi.org/10.1007/s12325-014-0156-2

Ejemplares similares

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi, Takanori, et al.
Publicado: (2017)

Topical Olopatadine Hydrochloride versus Ketotifen Fumarate for Allergic Conjunctivitis
por: Patel, Dharmistha, et al.
Publicado: (2018)

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
por: Uchio, Eiichi
Publicado: (2008)

Efficacy of Proactive Topical Antihistamine Use in Patients with Seasonal Allergic Conjunctivitis
por: Fukushima, Atsuki, et al.
Publicado: (2022)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
por: Ueda, Shoko, et al.
Publicado: (2022)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
por: Li, Shiyu, et al.
Publicado: (2023)

In vitro and in vivo performance of epinastine hydrochloride-releasing contact lenses
por: Minami, Takahiro, et al.
Publicado: (2019)

The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review
por: Zi, Yingxin, et al.
Publicado: (2020)

Allergic Sensitization to Perennial Allergens in Adults and Children Sensitized to Japanese Cedar or Japanese Cypress Pollen in Japan
por: Ohki, Masafumi, et al.
Publicado: (2014)

Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis
por: Ono, Santa J, et al.
Publicado: (2011)

Japanese cedar pollen upregulates the effector functions of eosinophils
por: Miyauchi, Sachiko, et al.
Publicado: (2021)

A Novel Approach of Preventing Japanese Cedar Pollen Dispersal That Is the Cause of Japanese Cedar Pollinosis (JCP) Using Pollen-Specific Fungal Infection
por: Hirooka, Yuuri, et al.
Publicado: (2013)

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
por: McLaurin, Eugene, et al.
Publicado: (2017)

The enantioselective synthesis of (S)-(+)-mianserin and (S)-(+)-epinastine
por: Roszkowski, Piotr, et al.
Publicado: (2015)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
por: Kurokawa, Tomoya, et al.
Publicado: (2022)

Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models
por: Tamura, Tadafumi
Publicado: (2012)

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
por: Torkildsen, Gail, et al.
Publicado: (2015)

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
por: McLaurin, Eugene B., et al.
Publicado: (2014)

Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice
por: Nagata, Yuka, et al.
Publicado: (2015)

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%
por: Greiner, Jack V, et al.
Publicado: (2011)

Relationships among Indoor, Outdoor, and Personal Airborne Japanese Cedar Pollen Counts
por: Yamamoto, Naomichi, et al.
Publicado: (2015)

Possibility of Japanese Cedar Pollen Causing False Positives in the Deep Mycosis Test
por: Kanno, Takashi, et al.
Publicado: (2021)

Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
por: Ayyappanavar, Shruti, et al.
Publicado: (2021)

Investigation of Cry J1 and Cry J2 Concentrations in Japanese Cedar Pollen and Non-Pollen Seasons
por: Tomizawa, Hiroki, et al.
Publicado: (2022)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
por: Epstein, Arthur B, et al.
Publicado: (2009)

Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study
por: Dakhale, Ganesh, et al.
Publicado: (2016)

Peripheral basophil reactivity, CD203c expression by Cryj1 stimulation, is useful for diagnosing seasonal allergic rhinitis by Japanese cedar pollen
por: Imoto, Yoshimasa, et al.
Publicado: (2015)

Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
por: Dudeja, Lakshey, et al.
Publicado: (2019)

Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure
por: Kanzaki, Sho, et al.
Publicado: (2016)

T‐cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens
por: Takaishi, Shinya, et al.
Publicado: (2019)

Factors Affecting the Number of Pollen Grains per Male Strobilus in Japanese Cedar (Cryptomeria japonica)
por: Kakui, Hiroyuki, et al.
Publicado: (2021)

Conjunctival macrophages act as antigen-presenting cells in the conjunctiva during the development of experimental allergic conjunctivitis
por: Ishida, Waka, et al.
Publicado: (2010)

Pharmacokinetic Comparison of Epinastine Using Developed Human Plasma Assays
por: Jeong, Seung-Hyun, et al.
Publicado: (2020)

Changes of micro-RNAs in asymptomatic subjects sensitized to Japanese cedar pollen after prophylactic sublingual immunotherapy
por: Hou, Bo, et al.
Publicado: (2015)

Number of seasonal exposures to Japanese cedar pollen increases the risk of sensitization: Observational study in Korean adults
por: Suh, Michelle J., et al.
Publicado: (2019)

Correction: Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice
Publicado: (2015)

Effects of a Cloth Panel Containing a Specific Ore Powder on Patients with Japanese Cedar Pollen Allergy During the Pollen Dispersal Season
por: Lee, Suni, et al.
Publicado: (2019)

Asthma in Patients With Japanese Cedar Pollinosis
por: Tanaka, Akihiko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_03gk8fjhsh1div8q8vr262a8du